9. Where Can I Find More Information About This Study?
Amgen has committed to make research results available to the public. This summary
has been provided as part of that commitment and should not be used for any other
purpose. It should not be considered to make a claim for any product or to guide
treatment decisions.
Some information in this summary may be different from the approved labeling for
etelcalcetide. Your healthcare professional should refer to the full prescribing
information for proper use of etelcalcetide.
To find out more about this study, check these websites:
 www.clinicaltrials.gov. Use the study identifier NCT02833857
 www.clinicaltrialsregister.eu. Use the study identifier 2015-005051-28
If you participated in the study and have questions about the study results, the doctor or
staff at your study site may be able to answer them.
devorppA
9